Sign in

NCT07537283Completed

Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy

A Randomized, Double-Blind, Placebo-Controlled Trial of Coenzyme Q10 as Adjunctive Therapy in Patients With Drug-Resistant Epilepsy

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

This study evaluates the efficacy and safety of coenzyme Q10 supplementation as adjunctive therapy in patients with drug-resistant epilepsy.

Status (registry)
Completed
Study type
Interventional
Enrollment
39 (actual)
First submitted
6 Apr 2026
Start date
7 Feb 2023
Primary completion date
28 Sept 2023
Lead sponsor
National Cheng-Kung University Hospital
Diseases
Epilepsy
NCT number
NCT07537283

What you commit to

  • Study type: Interventional
  • Participants enrolled: 39
  • From 7 Feb 2023 to the primary completion date, 28 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of coenzyme Q10 or other mitochondrial supplements within 4 weeks prior to enrollment.

Other illness

  • History of progressive neurological disease.
  • Severe systemic illness (e.g., uncontrolled cardiovascular, hepatic, or renal disease).
  • Known allergy or hypersensitivity to coenzyme Q10.

Other

  • Pregnancy or breastfeeding.
  • Participation in another clinical trial within the past 3 months.

Who the study is looking for

  • Adults aged 20 to 80 years.
  • Diagnosed with drug-resistant epilepsy.
  • Receiving stable anti-seizure medications for at least 4 weeks prior to enrollment.
  • Able to provide informed consent.
  • Willing and able to maintain seizure diaries throughout the study period.

Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Cheng Kung University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.